Metabolism and toxicity of styrene.
Peer Reviewed
Details
-
Description:The absorption, blood chemistry, distribution, excretion, and biotransformation of styrene (100425) are reviewed. Styrene may be absorbed into the blood stream by oral, inhalation, percutaneous, subcutaneous, or intraperitoneal exposure. The most common routes of absorption in industrial exposure are pulmonary and percutaneous. The recommended toxic limit value is 100 parts per million. The absorption rate of liquid styrene through the skin of the hand is 9 to 15 milligrams per square centimeter per hour. Concentrations of styrene found in rodent organs after exposure to the median lethal concentration are highest in the perirenal fat tissue. Blood is about 85 percent cleared of labeled styrene within 24 hours following subcutaneous injection; most of the radioactivity is excreted through the urine as carbon-dioxide. The major metabolite of styrene found in the urine of rodents is hippuric-acid (495692); in humans, the amount of urinary hippuric-acid is in the normal range of excretion. Mandelic-acid (90642) and phenylglyoxylic-acid (611734) are prominent metabolites found in humans. The production of mandelic-acid, phenylglyoxylic-acid, hippuric-acid, and of glucuronide conjugates increases in rats after pretreatment with phenobarbital (50066); coadministration of toluene (108883) reduces the formation of the three acids. The conversion of both styrene- oxide (96093) and styrene to hydroxyphenethylmercapturic-acid occurs in-vivo in rats and rabbits. The acute toxicity of styrene-oxide is about 4 times that of styrene. The most common toxic actions after exposure to styrene vapors or liquid are irritation of the skin, eyes, and respiratory tract and depression of the central nervous system. Chemical pneumonitis is a great hazard if aspiration occurs after ingestion of styrene. Epoxide intermediates have been implicated in hepatotoxicity and carcinogenicity. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0091-6765
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:115-119
-
Volume:11
-
NIOSHTIC Number:nn:00136863
-
Citation:Environ Health Perspect 1975 Jun; 11:115-119
-
Contact Point Address:Pharmacology and Therapeutics Department of Pharmacology U of Florida Coll of Medicine Gainesville, Fla 32603
-
CAS Registry Number:
-
Federal Fiscal Year:1975
-
Performing Organization:
-
Peer Reviewed:True
-
Start Date:19660101
-
Source Full Name:Environmental Health Perspectives
-
End Date:19701231
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:407812357467985867d003fc4fbe01a07749a8fcd16173ecb69140ef59a50a8bb7b4a4ed83a4a5053f3e59fda97e7352c064d91047d09e9a02829bb2ad47d7f9
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like